MGI(SH:688114) Xin Lang Cai Jing·2025-10-13 02:09Core Insights - BGI Genomics' stock price increased by 5.34% on October 13, reaching 72.59 CNY per share, with a total market capitalization of 30.235 billion CNY [1] - The company has seen a year-to-date stock price increase of 55.14%, with notable gains of 8.18% over the last 5 trading days and 14.69% over the last 60 days [2] Financial Performance - For the first half of 2025, BGI Genomics reported a revenue of 1.114 billion CNY, a year-on-year decrease of 7.90%, while the net profit attributable to shareholders was -104 million CNY, showing a year-on-year increase of 65.28% [2] - The company has distributed a total of 150 million CNY in dividends since its A-share listing [3] Shareholder Structure - As of June 30, 2025, the number of shareholders increased by 7.64% to 13,500, with an average of 15,766 circulating shares per shareholder, a decrease of 7.09% [2] - The top ten circulating shareholders include notable ETFs, with the largest being the Huaxia SSE Sci-Tech Innovation Board 50 ETF, holding 11.5323 million shares, a decrease of 245,600 shares from the previous period [3]